In collaboration with the University of Hong Kong – Shenzhen Hospital, ACCP will hold the first of a three-part series on pharmacotherapy and clinical practice this month in Shenzhen, China.
The initial Pharmacotherapy and Clinical Practice Series program will be offered over 2 days, May 14–15, 2016. The overall goal is to develop pharmacists’ competencies in pharmacotherapy and comprehensive medication management. The first offering will cover presentations and case applications on several cardiology, renal, and endocrine topics as well as practice development (Table).
Table. Program Sessions by Day
Day 1
Saturday, May 14, 2016 |
Day 2
Sunday, May 15, 2016 |
- Hypertension and Hypertensive Urgency
- Hypertension Case Applications
- Acute Coronary Syndrome and
Coronary Artery Disease
- Acute Coronary Syndrome and
Coronary Artery Disease Case Applications
- Acute Renal Failure
- Drugs in Dialysis
- Drug‐Induced Kidney Disease
- Developing and Advancing Your Practice I
|
- Diabetes Mellitus I
- Diabetes Mellitus II
- Diabetes Mellitus Case Applications
- Thyroid Disease
- Thyroid Case Applications
- Chronic Kidney Disease
- Complications of Chronic Kidney Disease
- Chronic Kidney Disease Case Applications
- Developing and Advancing Your Practice II
|
More information on this particular program, including program objectives, registration information, faculty, and agenda, is available at www.accp.com/docs/international/Shenzhen%20Program%20Announcement_final.pdf.
The second and third parts of the Pharmacotherapy and Clinical Practice Series are tentatively scheduled for October 15−16, 2016, and January 7−8, 2017, respectively. More information on these programs, once finalized, and other ACCP international offerings will be available at www.accp.com/international/calendar.aspx.